A Newer version of Cyberabad Times is now available.

Matrix Lab wins USFDA nod

Matrix Laboratories Ltd on Tuesday announced that it has received USFDA approval for its Active Pharmaceutical Ingredients (APIs) manufacturing facility located at Kazipally (Unit-II), near Hyderabad. The facility, that was commissioned in 2004, currently manufactures anti-retrovirals (ARVs) for the treatment of HIV / AIDS.

The approval will enable the Company to supply ARV APIs to the President Bush's US$15bn PEPFAR programme, besides other regulated markets. With the latest approval, the number of USFDA approved facilities of the company would be four, thus making it as one of the largest API manufacturing capacities in India to meet the regulatory market requirements. The company has filed cumulative 46 Drug Master Files (DMFs) with USFDA as of March 2005.